Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown

Armand Van Deun, Tom Decroo, Kya Jai Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Willem Bram De Rijk, Sabira Tahseen, Bouke Catherine de Jong, Leen Rigouts

Source: Eur Respir J, 58 (3) 2100783; 10.1183/13993003.00783-2021
Journal Issue: September
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Armand Van Deun, Tom Decroo, Kya Jai Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Willem Bram De Rijk, Sabira Tahseen, Bouke Catherine de Jong, Leen Rigouts. Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown. Eur Respir J, 58 (3) 2100783; 10.1183/13993003.00783-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002

23S rRNA mutations in linezolid-resistant clinical isolates of M. tuberculosis: A report of two cases
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013

Molecular epidemiological characterization of rpoB mutations in rifampicin-resistant of Mycobacterium tuberculosis in Kyrgyz Republic
Source: Eur Respir J 2005; 26: Suppl. 49, 655s
Year: 2005

Mutations of the gyrA gene of mycobacterium tuberculosis leading to XDR tuberculosis in Kyrgyz Republic
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011


Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting
Source: Eur Respir J 2005; 26: Suppl. 49, 655s
Year: 2005

M. tuberculosis W-strain: MDR or no?
Source: Eur Respir J 2003; 22: Suppl. 45, 555s
Year: 2003

Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010


Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST.
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017


RpoB and katG mutations as an epidemiologic markers of multi-drug-resistant M. tuberculosis strains isolated in Kyrgyz Republic
Source: Eur Respir J 2007; 30: Suppl. 51, 455s
Year: 2007

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


Identification of species of tuberculous and nontuberculous mycobacteria based on the hsp-65 gene polymorphism
Source: Annual Congress 2004 - Genetics and immunology of tuberculosis
Year: 2004


Diagnostic of sensitivity mycobacterium tuberculosis strains to isoniazid and rifampicin by simultaneous identification of mutations in rpoB, katG, inhA and ahpC-oxyR genes with biological microchips
Source: Eur Respir J 2006; 28: Suppl. 50, 379s
Year: 2006

Whole genome sequencing of Mycobacterium tuberculosis
Source: Eur Respir J, 52 (5) 1801163; 10.1183/13993003.01163-2018
Year: 2018



Analysis of mutations in multiple-drug-resistant M. tuberculosis strains isolated in Kyrgyzstan
Source: Eur Respir J 2006; 28: Suppl. 50, 380s
Year: 2006

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017
Year: 2017



Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013



Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
Source: Eur Respir J 2009; 34: 926-931
Year: 2009